间歇性跛行与慢性肢体威胁性缺血患者接受血管内治疗的临床特征、抗血栓治疗模式及预后结局比较
日本20家机构前瞻性多中心观察研究纳入692例患者808条肢体,比较间歇性跛行(IC)与慢性肢体威胁性缺血(CLTI)接受血管内治疗(EVT)后的特征与结局。CLTI组3年主要不良心血管事件(MACE)率和再干预率均约为IC组的两倍(42.3% vs 20.4%,46.8% vs 22.1%,log-rank p<0.001),炎症凝血异常与不良结局独立相关。
要点
- CLTI患者合并症更多、远端动脉病变更重、炎症凝血紊乱更明显。
- CLTI组3年MACE率42.3%、再干预率46.8%,均约为IC组的两倍。
- 校正死亡与截肢竞争风险后,CLTI与MACE、再干预的关联仅达边缘显著。
核心结论
- CLTI不仅以更多系统性合并症和远端病变为特征,还较IC存在更明显的炎症凝血紊乱。
- CLTI的MACE和再干预率约为IC的两倍,且 underlying 炎症凝血紊乱本身与这些结局相关。
研究设计与样本
- 前瞻性多中心观察研究(JPASSION研究),纳入日本20家机构的692例患者808条肢体,均接受血管内治疗(EVT)。
- 主要指标为3年主要不良心血管事件(MACE)率和再干预率。
主要发现
- IC占79.0%、CLTI占21.0%;CLTI组女性更多,功能状态受损、营养不良、合并症、高凝、高炎症、远端动脉病变更常见。
- CLTI组较IC组更多采用短程单联抗血小板和长程抗凝治疗,更晚使用西洛他唑。
- IC组以主髂动脉和股腘动脉病变为主,CLTI组以膝下动脉病变为主;CLTI组主髂动脉干预较少、膝下动脉干预较多。
- IC组与CLTI组踝肱指数(ABI)纵向变化模式不同(交互p=0.002),但两组EVT后ABI均改善(p<0.001)并持续维持。
- CLTI组足背及足底皮肤灌注压呈相似改善模式(交互p=0.181);两组Rutherford分级分布均改善(各p<0.001)。
关键数值与推荐
- D-二聚体升高(p=0.001)、年龄(p=0.043)、功能状态受损(p=0.018)、终末期肾病(p=0.019)与MACE独立相关。
- 校正死亡和截肢竞争风险后,红细胞沉降率升高(p=0.003)和膝下干预(p=0.002)与再干预独立相关。
- CLTI与MACE的关联仅达边缘显著:校正风险比1.700(95%CI 0.950-3.042,p=0.074)。
- CLTI与再干预的关联仅达边缘显著:校正风险比1.976(95%CI 0.999-3.909,p=0.05)。
局限性
- 原文在临床影响部分指出,需进一步研究阐明抗凝和抗炎治疗的作用,以促进外周动脉疾病介入后治疗的发展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The underlying difference between intermittent claudication (IC) and critical limb-threatening ischemia (CLTI) still remains unclear. This prospective multicenter observational study aimed to clarify differences in clinical features and prognostic outcomes between IC and CLTI, and prognostic factors in patients undergoing endovascular therapy (EVT). MATERIALS AND METHODS: A total of 692 patients with 808 limbs were enrolled from 20 institutions in Japan. The primary measurements were the 3-year rates of major adverse cardiovascular event (MACE) and reintervention. RESULTS: Among patients, 79.0% had IC and 21.0% had CLTI. Patients with CLTI were more frequently women and more likely to have impaired functional status, undernutrition, comorbidities, hypercoagulation, hyperinflammation, distal artery disease, short single antiplatelet and long anticoagulation therapies, and late cilostazol than patients with IC. Aortoiliac and femoropopliteal diseases were dominant in patients with IC and infrapopliteal disease was dominant in patients with CLTI. Patients with CLTI underwent less frequently aortoiliac intervention and more frequently infrapopliteal intervention than patients with IC. Longitudinal change of ankle-brachial index (ABI) exhibited different patterns between IC and CLTI (pinteraction=0.002), but ABI improved after EVT both in IC and in CLTI (p<0.001), which was sustained over time. Dorsal and plantar skin perfusion pressure in CLTI showed a similar improvement pattern (pinteraction=0.181). Distribution of Rutherford category improved both in IC and in CLTI (each p<0.001). Three-year MACE rates were 20.4% and 42.3% and 3-year reintervention rates were 22.1% and 46.8% for patients with IC and CLTI, respectively (log-rank p<0.001). Elevated D-dimer (p=0.001), age (p=0.043), impaired functional status (p=0.018), and end-stage renal disease (p=0.019) were independently associated with MACE. After considering competing risks of death and major amputation for reintervention, elevated erythrocyte sedimentation rate (p=0.003) and infrainguinal intervention (p=0.002) were independently associated with reintervention. Patients with CLTI merely showed borderline significance for MACE (adjusted hazard ratio 1.700, 95% confidence interval 0.950-3.042, p=0.074) and reintervention (adjusted hazard ratio 1.976, 95% confidence interval 0.999-3.909, p=0.05). CONCLUSIONS: The CLTI is characterized not only by more systemic comorbidities and distal disease but also by more inflammatory coagulation disorder compared with IC. Also, CLTI has approximately twice MACE and reintervention rates than IC, and the underlying inflammatory coagulation disorder per se is associated with these outcomes. CLINICAL IMPACT: The underlying difference between intermittent claudication (IC) and critical limb-threatening ischemia (CLTI) still remains unclear. This prospective multicenter observational study, JPASSION study found that CLTI was characterized not only by more systemic comorbidities and distal disease but also by more inflammatory coagulation disorder compared to IC. Also, CLTI had approximately twice major adverse cardiovascular event (MACE) and reintervention rates than IC. Intriguingly, the underlying inflammatory coagulation disorder per se was independently associated with MACE and reintervention. Further studies to clarify the role of anticoagulation and anti-inflammatory therapies will contribute to the development of post-interventional therapeutics in the context of peripheral artery disease.
引用
- Kawarada O, Zen K, Hozawa K, et al. Characteristics, Antithrombotic Patterns, and Prognostic Outcomes in Claudication and Critical Limb-Threatening Ischemia Undergoing Endovascular Therapy. J Endovasc Ther. 2022. PMID: 36416475. doi:10.1177/15266028221134886
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。